About Us

Bioceptive was founded in September 2010 to address a long-term lack of innovation in certain areas of women’s health. Our mission is to development medical devices that improve a woman’s health care experience, improve outcomes, increase access to difficult procedures, and improve the health care delivery experience for providers.

The company’s platform technology is based on a new approach to intrauterine devices–the replacement of the sharp, tongs-like instrument called a tenaculum with a gentler, suction-based device that offers less traumatic cervical engagement and entry into the uterus for gynecological procedures.

Our second device is an innovative, intuitive IUD insertion system developed to decrease the adverse events caused by current insertion tools and techniques. It will also expand access to the IUD worldwide by providing a more intuitive and less painful insertion procedure. Bioceptive is in development stage of its patent-pending device and expects to seek regulatory approval in the U.S. and Europe in 2015.

The Bioceptive IUD Inserter replaces the use of a cervical tenaculum, a uterine sound, an Os finder, the current IUD inserters, and surgical scissors to cut the strings of the IUD. The inserter works with each of the two most popular layouts of IUDs: the Nova-T design (Mirena by Bayer HealthCare; Medicines360) and the Copper-T design (Paragard by Teva Pharmaceuticals; and others globally).

We have a pipeline of other great products to improve women’s health provision, so stay tuned for future developments!

Interested in learning more? Meet our management team here or read about some of our investors.

Comments are closed.